4.8 Article

Pharmacokinetics of Py-Im Polyamides Depend on Architecture: Cyclic versus Linear

Journal

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 134, Issue 18, Pages 7995-7999

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ja302588v

Keywords

-

Funding

  1. Alexander von Humboldt foundation
  2. California Tobacco-Related Disease Research Program [19FT-0105]
  3. NIH (NRSA) [1F32CA156833, 5F32CA139883]
  4. Ellison Medical Foundation [AG-SS-2256-09]
  5. National Institutes of Health [GM051747]

Ask authors/readers for more resources

The pharmacokinetic properties of three pyrrole-imidazole (Py-Im) polyamides of similar size and Py-Im content but different shape were studied in the mouse. Remarkably, hairpin and cyclic oligomers programmed for the same DNA sequence 5'-WGGWWW-3' displayed distinct pharmacokinetic properties. Furthermore, the hairpin 1 and cycle 2 exhibited vastly different animal toxicities. These data provide a foundation for design of DNA binding Py-Im polyamides to be tested in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available